Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · September 22, 2022

Prognosis of Patients With Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy Based on Tumor Subtype and Germline BRCA Mutation

Breast Cancer Research and Treatment


Additional Info

Disclosure statements are available on the authors' profiles:

Breast Cancer Research and Treatment
Prognostic role of tumor subtype and germline BRCA mutation in advanced breast cancer patients treated with palbociclib plus endocrine therapy
Breast Cancer Res Treat 2022 Sep 07;[EPub Ahead of Print], SY Park, KJ Suh, DW Lee, HS Ryu, M Kim, SH Kim, KH Lee, TY Kim, JH Kim, IA Park, SA Im

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading